Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 15,286 | 11,962 | 5,268 | 97 | 4 |
| Cost of Goods | 2,263 | 1,704 | 845 | 526 | N/A |
| Gross Profit | 13,023 | 10,258 | 4,423 | -429 | 4 |
| Operating Expenses | 102,007 | 89,193 | 77,667 | 72,020 | 50,266 |
| Operating Income | -88,721 | -78,231 | -72,399 | -71,923 | -50,262 |
| Other Income | 963 | 876 | 786 | 601 | 500 |
| Pre-tax Income | -87,758 | -77,355 | -71,613 | -71,322 | -49,762 |
| Income Tax | 85 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -87,843 | -78,696 | -71,613 | -71,322 | -49,762 |
| Net Income | $-87,843 | $-78,696 | $-71,613 | $-71,322 | $-49,762 |
| EPS Basic Total Ops | -0.72 | -0.65 | -0.61 | -0.63 | -0.45 |
| EPS Basic Continuous Ops | -0.72 | -0.66 | -0.61 | -0.63 | -0.45 |
| EPS Diluted Total Ops | -0.72 | -0.65 | -0.61 | -0.63 | -0.45 |
| EPS Diluted Continuous Ops | -0.72 | -0.66 | -0.61 | -0.63 | -0.45 |
| EBITDA(a) | $-88,195 | $-77,657 | $-71,421 | $-71,462 | $-50,358 |